Market Access & Regulatory Strategy for France
Integrated Medical, Commercial & Regulatory Expertise
to support confident entry and sustainable growth in the French market.
Access Pharma Consulting (APC) supports international pharmaceutical, biotech, and medical device companies across the full French market access and regulatory journey, from early entry strategy to post-launch optimization.
We align regulatory pathways, reimbursement strategy, medical positioning, and stakeholder engagement to deliver compliant, executable, and sustainable market success in France.
About APC
About Access Pharma Consulting
Market Access & Regulatory Strategy for France
Access Pharma Consulting is a France-based market access and regulatory consulting firm supporting pharmaceutical, biotech, medical device, and medical cannabis companies entering or expanding in the French market.
We provide senior-level regulatory strategy, market access planning, pricing and reimbursement expertise, and stakeholder engagement support aligned with ANSM and HAS requirements.
Our consultancy supports international healthcare companies across specialty and hospital-driven markets, addressing complex French regulatory pathways and access challenges.
With over 10 years of pharmaceutical industry leadership, Access Pharma Consulting combines medical expertise, regulatory intelligence, and commercial strategy to accelerate successful market entry in France.
We work directly with executive teams to design decision-ready, locally grounded, and globally aligned go-to-market strategies for France.
More than navigating the French healthcare system, we unlock it.
Strategic Market Access &
Regulatory Services
Tailored Expertise Across the Pharmaceutical & Biotech Product Journey
At APC, we design and deliver high-level market access and regulatory strategies tailored to your product, development stage, and market objectives.
Whether you're exploring the French market, preparing a launch, or refining your access strategy, we align medical, regulatory, and commercial dimensions to unlock success.
Why Choose Access Pharma Consulting for Market Access ?
Led by Dr. Dounia Farajallah, PharmD & ESSEC-trained strategist, with a strong pharmaceutical industry background, combining medical insight with executive-level business and market access expertise.
More than 12 years of experience in the pharmaceutical industry, including leadership roles across international environments and hands-on involvement in the launch and management of a French subsidiary for a global pharma group.
Proven experience in regulatory approvals, market access strategy, and pricing negotiations across complex therapeutic areas.
Deep mastery of the French healthcare system, including ANSM and HAS interactions, reimbursement pathways, and hospital tenders.
Acting as a single senior interface to accelerate decision-making, reduce regulatory risk, and avoid costly misalignment between medical, regulatory and commercial teams across complex products and markets.
![24093 [Converted]-01.jpg](https://static.wixstatic.com/media/46f5a9_49032bdb9c9748b2a8891fc2bb42dfce~mv2.jpg/v1/fill/w_421,h_281,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/46f5a9_49032bdb9c9748b2a8891fc2bb42dfce~mv2.jpg)
Core Market Access & Regulatory Service Areas :
Regulatory Affairs & Early Access Pathways
End-to-end regulatory support for the French market, including AMM submissions and early access pathways (ATU).
We advise on regulatory strategy and dossier positioning, aligned with ANSM requirements, to support informed market entry decisions..
Market Access Strategy & Stakeholder Mapping
Tailored market access and reimbursement strategies aligned with product maturity and value proposition.
We support pricing strategy, market segmentation, competitive positioning, and stakeholder mapping within the French reimbursement framework, aligned with HAS expectations.
Medical Affairs & Stakeholder Strategy
Strategic medical affairs support to strengthen scientific positioning in the French context.
We align medical strategy with local clinical practice, key opinion leader engagement, and institutional expectations.
Executive Strategic Workshops & Training
Executive-level workshops and targeted training for global and local leadership teams.
We provide decision-makers with a clear understanding of the French healthcare system, regulatory pathways, and reimbursement dynamics.
Compliance & Post-Launch Support
Review and oversight of medical, scientific, and promotional materials to ensure compliance with French regulations.
We support compliant post-launch activities and sustainable medical information practices.
Request a Strategic Discussion
Let’s Accelerate Your Strategy in France
Access Pharma Consulting (APC) supports pharmaceutical, biotech, medical device, and medical cannabis companies entering or scaling in the French market through senior-level strategic advisory, regulatory expertise, and market access execution.
Whether you are defining your France entry strategy, preparing regulatory or reimbursement submissions, or aligning with key institutional and clinical stakeholders, APC provides the clarity and executive-level support needed to move forward with confidence.
Let’s turn regulatory and market complexity into a clear, executable strategy.
Contact us to explore how we can support you.
Follow Us